Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: A retrospective study from the European Group for Blood and Marrow Transplantation

Blood

Volumn 121, Issue 3, 2013, Pages 440-446

  Roos Weil, Damien ^a   Dietrich, Sascha ^b,c   Boumendil, Ariane ^c   Polge, Emmanuelle ^d   Bron, Dominique ^e   Carreras, Enric ^f   Atienza, Arturo Iriondo ^g   Arcese, William ^h   Beelen, Dietrich W ⁱ   Cornelissen, Jan J ^j   Kröger, Nicolaus ^k   Milone, Giuseppe ^l   Rossi, Giuseppe ^m   Jardin, Fabrice ⁿ   Peters, Christina ^o   Rocha, Vanderson ^p   Sureda, Anna ^q   Mohty, Mohamad ^r   Dreger, Peter ^b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c European Society for Blood and Marrow Transplantation   (France)

^d Acute Leukemia Working Party   (France)

^e JULES BORDET INSTITUTE   (Belgium)

^f Official Spanish Register of Bone Marrow Donors   (Spain)

^g HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^h UNIVERSITY OF ROME TOR VERGATA   (Italy)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j ERASMUS MEDICAL CENTER   (Netherlands)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l Ospedale Ferrarotto   (Italy)

^m SPEDALI CIVILI   (Italy)

ⁿ CENTRE HENRI BECQUEREL   (France)

^o ST ANNA CHILDREN S HOSPITAL   (Austria)

^p SAINT LOUIS HOSPITAL   (France)

^q ADDENBROOKE S HOSPITAL   (United Kingdom)

^r NANTES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUDARABINE; MELPHALAN; THIOTEPA; TREOSULFAN;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLASTIC NK CELL LYMPHOMA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISEASE REGISTRY; FEMALE; HUMAN; INCIDENCE; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SIBLING; STEM CELL TRANSPLANTATION;

EID: 84872470209     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-08-448613     Document Type: Article

References (20)

1. Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002;99(5):1556-1563. (Pubitemid 34533026)
2. Petrella T, Bagot M, Willemze R, et al. Blastic NKcell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123(5):662-675. (Pubitemid 40586484)
3. Reichard KK, Burks EJ, Foucar MK, et al. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol. 2005;29(10):1274-1283. (Pubitemid 41368761)
4. Herling M, Jones D. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. 2007;127(5):687-700.
5. Willemze R, Jaffe ES, Burg G, et al. WHOEORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-3785.
6. Lee JK, Schiller G. Blastic plasmacytoid dendritic cell neoplasm. Clin Adv Hematol Oncol. 2012; 10(1):60-62.
7. Reimer P, Rudiger T, Kraemer D, et al. What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant. 2003;32(7): 637-646. (Pubitemid 37258618)
8. Assaf C, Gellrich S, Whittaker S, et al. CD56- positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol. 2007;60(9):981-989. (Pubitemid 47441929)
9. Dalle S, Beylot-Barry M, Bagot M, et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol. 2010;162(1):74-79.
10. Lucioni M, Novara F, Fiandrino G, et al. Twentyone cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood. 2011;118(17):4591-4594.
11. Jardin F, Ruminy P, Parmentier F, et al. TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm. Br J Haematol. 2011;153(3):413-416.
12. Dietrich S, Andrulis M, Hegenbart U, et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant. 2011;17(8):1250-1254.
13. Garnache-Ottou F, Feuillard J, Ferrand C, et al. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol. 2009; 145(5):624-636.
14. Giralt S, Ballen K, Rizzo D, et al. Reducedintensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15(3):367-369.
15. Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009; 15(12):1628-1633.
16. Ruan PK, Gray RJ. Analyses of cumulative incidence functions via non-parametric multiple imputation. Stat Med. 2008;27(27):5709-5724.
17. Fine J, Gray R. A Proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
18. Ben Amor R, Hicheri Y, Pautas C, et al. Successful non-myeloablative allogeneic HLA-identical stem cell transplantation for CD4/CD56 positive acute leukemia. Transplantation. 2007;84(8): 1066-1067. (Pubitemid 350287392)
19. Ham JC, Janssen JJ, Boers JE, Kluin PM, Verdonck LF. Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm. J Clin Oncol. 2012;30(8):e102-e103.
20. Duff JM, Rossi ML, Fromm J, Hsu JW. A 21-yearold woman with blastic NK cell leukemia/lymphoma who achieved durable remission with HyperCVAD and unrelated umbilical cord blood transplant. Clin Adv Hematol Oncol. 2011;9(7): 566-568.